ArticleJournal of Taibah University Medical Sciences2025
Expression of alpha-smooth muscle actin in salivary mucoepidermoid and adenoid cystic carcinomas: A comparative immunohistochemical study.
Article in Journal of Taibah University Medical Sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Alpha-smooth muscle actin (α-SMA) is crucial in fibrogenesis. Salivary gland tumor types exhibit varying degrees of α-SMA expression because myoepithelial cells play diverse roles in their formation. The present study compared the immunohistochemical expression of α-SMA in mucoepidermoid and adenoid cystic carcinoma according to the grades and variants. Methodology: Sections of formalin-fixed, paraffin-embedded tissue blocks obtained from 50 cases of salivary gland carcinoma from 2011 to 2021 were stained using α-SMA monoclonal antibodies for immunohistochemical analysis. Results: The mean α-SMA scores did not differ significantly among the three mucoepidermoid carcinoma histology levels. No notable variations in α-SMA expression were observed in the mucoepidermoid carcinoma cases analyzed. By contrast, high-grade adenoid cystic carcinoma cases had substantially higher α-SMA scores than cases with low or intermediate grades. The α-SMA scores did not differ significantly between the low and intermediate grades. Among the histological variants, more cases with highly significant α-SMA scores were found in solid types compared with tubular, cribriform, or combined types. Furthermore, patients with cribriform growth had significantly higher α-SMA scores than those with tubular tumor growth. Overall, the percentage of high reactivity (expression) (α-SMA score 4+) was significantly higher in adenoid cystic carcinoma cases than mucoepidermoid carcinoma cases. Conclusions: These findings highlight the importance of α-SMA as a tumor marker for differentiating between mucoepidermoid and adenoid cystic carcinoma in terms of the tumor grading, histological variant, and expression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.